UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 29.469
NA - Nord America 19.182
EU - Europa 6.614
SA - Sud America 1.767
OC - Oceania 208
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 18
Totale 57.377
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 23.088
US - Stati Uniti d'America 18.866
SG - Singapore 2.277
CN - Cina 1.983
BR - Brasile 1.493
IT - Italia 1.445
UA - Ucraina 1.420
RU - Federazione Russa 919
VN - Vietnam 814
DE - Germania 775
IE - Irlanda 633
KR - Corea 450
TR - Turchia 402
SE - Svezia 346
FI - Finlandia 314
GB - Regno Unito 232
CA - Canada 185
EE - Estonia 146
IN - India 124
NZ - Nuova Zelanda 104
AR - Argentina 101
AU - Australia 98
MX - Messico 72
NL - Olanda 58
EC - Ecuador 55
PL - Polonia 54
AT - Austria 53
BD - Bangladesh 53
FR - Francia 51
JP - Giappone 42
ID - Indonesia 41
ES - Italia 37
IQ - Iraq 33
CZ - Repubblica Ceca 30
ZA - Sudafrica 28
CO - Colombia 26
MA - Marocco 23
PK - Pakistan 22
PY - Paraguay 22
UZ - Uzbekistan 22
IL - Israele 20
VE - Venezuela 20
CL - Cile 19
EU - Europa 16
AE - Emirati Arabi Uniti 15
DO - Repubblica Dominicana 14
PE - Perù 12
BE - Belgio 11
UY - Uruguay 11
EG - Egitto 10
KE - Kenya 9
LT - Lituania 9
AL - Albania 8
BG - Bulgaria 8
JM - Giamaica 8
SA - Arabia Saudita 8
ET - Etiopia 7
IR - Iran 7
NP - Nepal 7
TN - Tunisia 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
DK - Danimarca 6
DZ - Algeria 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
SV - El Salvador 5
BW - Botswana 4
BY - Bielorussia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
ME - Montenegro 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PR - Porto Rico 4
RS - Serbia 4
TW - Taiwan 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
TJ - Tagikistan 3
AO - Angola 2
BS - Bahamas 2
BZ - Belize 2
Totale 57.318
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.069
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Dallas 1.118
Singapore 840
Houston 736
Woodbridge 616
Dublin 594
Ashburn 567
Dong Ket 459
Nanjing 399
Andover 368
Izmir 364
Beijing 360
Moscow 314
Boardman 298
Pellezzano 264
Düsseldorf 216
Mestre 203
Los Angeles 163
Naples 149
Tallinn 146
Norwalk 143
Ho Chi Minh City 136
Shenyang 134
Fairfield 131
São Paulo 129
Salerno 122
Hebei 121
Munich 121
Changsha 110
Nanchang 108
Dearborn 107
Jiaxing 85
New York 83
Hanoi 71
The Dalles 67
Rome 65
Redwood City 60
Tianjin 56
Nuremberg 54
Rio de Janeiro 52
San Diego 49
Pune 48
Brooklyn 47
Auckland 43
Santa Clara 43
Columbus 42
Sydney 42
Warsaw 42
Milan 38
Montreal 37
San Francisco 37
Seoul 37
Belo Horizonte 36
Stockholm 36
Council Bluffs 35
Turku 35
West Jordan 35
Amsterdam 33
Washington 33
Tokyo 32
Cambridge 31
Seattle 31
Brasília 30
Curitiba 29
Jinan 29
Casoria 28
Boston 27
Ottawa 27
Atlanta 26
London 26
Phoenix 25
Porto Alegre 24
Chicago 23
Lappeenranta 23
Chennai 22
Fort Worth 21
Guangzhou 21
Guayaquil 21
Campinas 20
Poplar 20
Springfield 19
Tashkent 19
Denver 18
Guarulhos 18
Venezia 18
Vienna 18
Ankara 17
Quito 17
Shanghai 17
Toronto 17
Baghdad 16
Haiphong 16
Johannesburg 16
Melbourne 16
Brno 15
Totale 46.043
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.163
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 959
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 924
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 911
Trial of Deferiprone in Parkinson's Disease 655
Sex Differences in Parkinson’s Disease: From Bench to Bedside 623
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 580
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 572
Cognitive impairment in nondemented Parkinson's disease. 561
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 548
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 529
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 527
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 514
Gender differences in microRNA expression in levodopa-naive PD patients 512
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 501
A simulation tool to plan daily nurse requirements 501
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 485
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 476
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 454
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 435
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 434
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 427
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 426
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 411
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 411
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 408
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 389
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 374
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 369
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 359
Neurotransmission in Parkinson's disease: beyond dopamine. 353
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 331
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 331
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 310
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 304
Bilateral facial palsy after COVID-19 vaccination 301
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 301
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 290
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 289
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 285
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 281
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 280
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 274
A novel phenotype in an Italian family with a rare progranulin mutation 270
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 258
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 257
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 254
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 247
Trial of Cinpanemab in Early Parkinson's Disease 246
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 241
Classifying Different Stages of Parkinson’s Disease Through Random Forests 233
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 232
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 227
Metabolomics in Parkinson's disease 217
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 209
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 198
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 194
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 194
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 192
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 180
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 179
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 173
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 171
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 168
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 165
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 164
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 159
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 157
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 156
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 147
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 146
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 144
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 144
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 141
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 140
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 139
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 138
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 137
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 137
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 136
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 134
Affective theory of mind in patients with Parkinson's disease: comment 129
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 127
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 126
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 126
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 125
The natural history of multiple system atrophy: A prospective European cohort study 124
Increased bilirubin levels in de novo Parkinson's disease 123
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 123
Normative data for the Montreal Cognitive Assessment in an Italian population sample 122
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 121
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 120
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 120
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 119
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 119
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 118
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 118
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 117
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 117
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 115
Totale 29.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.093 0 0 0 0 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202627.415 4.870 11.165 9.973 1.342 65 0 0 0 0 0 0 0
Totale 58.450